Synthesis, Spectral Analysis and Evolution of Antimicrobial Activity of Schiff Base of Cyanoacetohydrazide

• Autorzy: Jadeja J. , Mamtora M. , Gondaliya M. B. , Manawar R. , Shah M. K.

Identyfikatory

DOI

10.18052/www.scipress.com/ILCPA.52.100

• Języki publikacji: EN

Abstrakty

EN

In search of some antimicrobial agents, synthesis of some Schiff base of cyanoacetohydrazide derivatives has been reported. The structures of all the synthesized compounds were established on the bases of various spectroscopic methods. All Schiff base were screened for antimicrobial activity. cyanoacetohydrazide were found to possess better antimicrobial potential.

Słowa kluczowe

EN

Schiff’s base; Spectral analysis; antimicrobial activity; Cyanoacetohydrazide; Aldehyde

• Wydawca: Przedsiębiorstwo Wydawnictw Naukowych "DARWIN"
• Czasopismo: International Letters of Chemistry, Physics and Astronomy
• Rocznik: 2015
• Tom: Vol. 52
• Strony: 100--110
• Opis fizyczny: Bibliogr. 15 poz., rys., wz.

Twórcy

autor

Jadeja J.

• Chemical Research Laboratory, Department of Chemistry Saurashtra University, Rajkot - 360005

autor

Mamtora M.

• Chemical Research Laboratory, Department of Chemistry Saurashtra University, Rajkot - 360005

autor

Gondaliya M. B.

• Chemical Research Laboratory, Department of Chemistry Saurashtra University, Rajkot - 360005

autor

Manawar R.

• Chemical Research Laboratory, Department of Chemistry Saurashtra University, Rajkot - 360005

autor

Shah M. K.

• Chemical Research Laboratory, Department of Chemistry Saurashtra University, Rajkot - 360005

Bibliografia

• [1] S. Rallas, N. Gulerman, H. Erdeniz, Farmaco 57 (2002) 171-174.
• [2] A. Gursoy, N. Terzioglu, G. Otuk, Eur. J. Med. Chem. 32 (1997) 753-757.
• [3] C. Walsh, Nature 406 (2000) 775-778.
• [4] S. Rollas, N. Kalyoncuoğlu, D. Sur-Altiner and Y. Ye- ğenoğlu, Pharmazie, Vol. 48, No. 4, (1993), 308-309.
• [5] S. Papakonstantinou-Garoufalias, N. Pouli, P.-Marakos and A. Chytyro-Glouladas, Farmaco, Vol. 57, No. 12, (2002), pp. 973-977.
• [6] M. Kidwai, R. Kumar, A. Srivastava and H. P. Gupta, Bioorganic Chemistry, Vol. 26, No. 5, (1998), pp. 289-294.
• [7] V. V. Kachhadia, M. R. Patel and H. S. Joshi, Journal of the Serbian Chemical Society, Vol. 70, No. 2, (2005), pp. 153-161.
• [8] P. K. KadabaCurrent Medicinal Chemistry, Vol. 10, No. 20, (2003), pp. 2081-2108.
• [9] İ. küçükgüzel, Ş. G. Küçükgüzel, S. Rollas, G. Ö.-Saniş, O. Özdemir, I. Bayrak, T. Altuğand J. P. Stables, Farmaco, Vol. 59, No. 11, (2004), pp. 893-901.
• [10] M. D. Mullican, M. W. Wilson, D. T. Connor, C. R. Kostlan, D. J. Schrier and R. D. Dyer, Journal of Medicinal Chemistry, Vol. 36, No. 8, (1993), pp. 1090-1099.
• [11] E. Palaska, G. Şahin, P. Kelicen, N. T. Durlu and G. Altinok, Farmaco, Vol. 57, No. 2, (2002), pp. 101-107.
• [12] A.Varvaresou, T. Siatra-Papastaikoudi, A. Tsotinis, A. TsantiliKakoulidou and A. Vamvakides, Farmaco, Vol. 53, No. 5, (1989), pp. 320-326.
• [13] B. S. Holla, B. Veerendra, M. K. Shivanada and B. Poo- jary, european Journal of Medicinal Chemistry, Vol. 38, No. 7-8, (2003), pp. 759-767.
• [14] J. H. Lange, H. H. Stuivenberg, H. K. Coolen, T. J. Adolfs, A. C. McCreary, H.G. Keizer, H. C. Wals, W.Veerman, A. J. Borst, W. de Looff, P. C. Verveer and C. G. Kruse, Journal of Medicinal Chemistry, Vol. 48, No. 6, (2005), pp. 1823-1838.
• [15] N. Szuber, J.L. Buss, S.S. Lin, H. Felfly, M. Trudel, P. Ponka, Exp. Hematol. 36(2008) 773–785.